Showing results (341-350 of 361) with videos related to
Sort By:
Pageof 37
Journal of Translational Medicine|April 6, 2023
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myelomaMaria-Alexandra Papadimitriou, Konstantinos Soureas, Aristea-Maria Papanota, et al.International Journal of Cancer|July 5, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patientsKonstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, et al.Cancer Research|February 20, 2003
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo, Dionyssios Katsaros, Andreas Scorilas, et al.British Journal of Haematology|February 28, 2024
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcomeKonstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, et al.BMC Medicine|August 23, 2021
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patientsIoannis P Trougakos, Evangelos Terpos, Christina Zirou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphomaAmanda Psyrri, Sotirios Papageorgiou, Elisavet Liakata, et al.The Journal of Molecular Diagnostics : JMD|May 15, 2012
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinomaHala Faragalla, Youssef M Youssef, Andreas Scorilas, et al.Oncotarget|July 8, 2016
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosisEmilie Dalloneau, Nadine Baroukh, Konstantinos Mavridis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinomaEleftherios P Diamandis, Andreas Scorilas, Stefano Fracchioli, et al.Molecular Cancer|June 3, 2014
Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinomaHala Girgis, Olena Masui, Nicole Ma White, et al.Pageof 37